Methadone/Buprenorphine Cross-Over Study - 4
Sponsor
National Institute on Drug Abuse (NIDA) (NIH)
Overall Status
Completed
CT.gov ID
NCT00000208
Collaborator
(none)
0
1
Study Details
Study Description
Brief Summary
The purpose of this study is to explore ways to cross patients over from methadone to buprenorphine.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 2 |
Study Design
Study Type:
Interventional
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Methadone/Buprenorphine Cross-Over Study
Study Start Date
:
Feb 1, 1992
Outcome Measures
Primary Outcome Measures
- Drug use []
- Withdrawal symptoms []
- Opiate craving []
Eligibility Criteria
Criteria
Ages Eligible for Study:
21 Years
to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
M/F ages 21-50. Opiate dependence according to DSM-IV critera. Self-reported use within the last 30 days. Agreeable to conditions of study and signed informed consent.
Exclusion Criteria:
Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Friends Research Institute | Los Angeles | California | United States | 90025 |
Sponsors and Collaborators
- National Institute on Drug Abuse (NIDA)
Investigators
- Principal Investigator: Walter Ling, M.D., Friends Research Institute, Inc.
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00000208
Other Study ID Numbers:
- NIDA-06082-4
- R18-06082-4
First Posted:
Sep 21, 1999
Last Update Posted:
Aug 17, 2005
Last Verified:
Sep 1, 1993